Volunteering

Volunteering

We firmly believe that your role as study volunteers in clinical research is crucial in the advancement of medicine. Without your participation, new ways to prevent, diagnose, and treat diseases cannot be achieved. You are our medical heroes!

We're Here to Answer Your Questions

Our recruitment staff is available Monday through Friday to answer your questions. If you call outside these hours, leave a message, and your call will be returned. If you are interested in a study for healthy volunteers, please call 919-613-6244. If you are interested in a study for a specific medical condition, please call 919-613-6246. We are here to help!

contextual photo

We recognize how important you are to our mission and are committed to give back to you. When you participate in our studies, you will have the option to receive updates on study results and publications. You will dictate the frequency and method by which we reach out to you. This way, you will see quickly and directly the impact of your participation in accelerating new therapies to humans.

Volunteer Registry

If you are interested in being contacted for future research studies when it appears that you may be eligible based on the information you provide us, join our Research Volunteer Registry.


Additionally, you can view our other study opportunities below.

Asthma Patient Registry

The Duke Early Phase Clinical Research Unit is enrolling people with asthma into the American Lung Association's Asthma Clinical Research Center patient registry. If you have asthma and are interested in becoming involved in ALA-sponsored studies, you may participate in the registry regardless of your smoking status. Registry participants will play a role in furthering medical knowledge about the condition and be notified of any studies they might be qualified to participate in.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-684-1554 or DCRIvolunteer@duke.edu.

Drug Study for Skin Disease

Volunteers with various types of skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women who are at least 18 years old and are not currently using a biologic agent to treat their skin disease. Participation involves 15 outpatient visits to the Duke Early Phase Clinical Research Unit over the course of approximately 5 months.

Study volunteers might receive a placebo rather than the active study drug. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or DCRIvolunteer@duke.edu.

Investigational Drug Study for Children or Adults with Pompe Disease

Adults and children who are at least 3 years old are needed to participate in a research study to assess the safety and effectiveness of an investigational drug that is being developed as a potential treatment for Pompe Disease. Eligible participants will be Pompe Disease patients who have not yet been treated with enzyme replacement therapy. Participation will require biweekly infusion visits at the Duke Early Phase Clinical Research Unit for approximately 3 years. Compensation is provided to enrolled participants.

For more information

Please contact study coordinator Wan Lan Liang at 919-668-0972 or wan.liang@duke.edu.

Investigational Vaccine Study for C. Diff

Men and women who are at least 50 years of age are needed to participate in a research study to determine the safety and efficacy of an investigational vaccine that is being developed as a potential prevention for Clostridium difficile infection.

Eligible participants will be people for whom the following applies:

  • Have made 2 emergency room visits in the past 12 months; or
  • Have been hospitalized for at least 2 nights in the past 12 months; or
  • Have plans to stay in the hospital for at least 2 nights; or
  • Live in a nursing facility; or
  • Have made at least 10 outpatient hospital visits in the past 12 months; or
  • Have been prescribed or given antibiotics in the past 12 weeks

Participation will require 5 outpatient visits over the course of 7 months, and participants will receive 3 doses of the study vaccine or a placebo during the course of the study.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6246 or DCRIvolunteer@duke.edu.

Lupus Drug Study

Men and women diagnosed with lupus are needed to participate in a study for an investigational drug that is being developed as a potential treatment for lupus. Eligible participants will be people between the ages of 18 and 55 who do not smoke and weigh less than 220 pounds.

Participation will require 18 outpatient visits to the Duke Early Phase Clinical Research Unit over the course of approximately 5 months. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6246 or DCRIvolunteer@duke.edu.

Volunteers Needed for Flu Vaccine Research Study

Healthy women and men are needed to participate in a research study to determine the safety and performance of an investigational vaccine that is being developed to protect against influenza. Eligible participants will be 18 to 39 years of age. Participation will involve receiving 2 doses of the study vaccine or a placebo and 11 outpatient visits to the Duke Early Phase Clinical Research Unit, or it may require 9 outpatient visits and 1 inpatient admission. The inpatient admission will last for 7 consecutive nights. Enrolled participants will receive financial compensation.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or DCRIvolunteer@duke.edu.

Volunteers with COPD or Emphysema Needed

Men and women who have been diagnosed with COPD or emphysema are needed to participate in a research study to determine the potential effectiveness of an antihypertensive drug in the treatment of COPD or emphysema. Eligible participants will be at least 40 years old and have no plans to move out of the area for at least a year. Participation will require 7 or 8 visits to the Duke Early Phase Clinical Research Unit over the course of approximately one year. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or DCRIvolunteer@duke.edu.